BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 27444718)

  • 1. Poorly Differentiated Clusters: Clinical Impact in Colorectal Cancer.
    Barresi V; Reggiani Bonetti L; Ieni A; Caruso RA; Tuccari G
    Clin Colorectal Cancer; 2017 Mar; 16(1):9-15. PubMed ID: 27444718
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Histologic grading based on counting poorly differentiated clusters in preoperative biopsy predicts nodal involvement and pTNM stage in colorectal cancer patients.
    Barresi V; Bonetti LR; Ieni A; Branca G; Baron L; Tuccari G
    Hum Pathol; 2014 Feb; 45(2):268-75. PubMed ID: 24289972
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Histological grading in colorectal cancer: new insights and perspectives.
    Barresi V; Reggiani Bonetti L; Ieni A; Caruso RA; Tuccari G
    Histol Histopathol; 2015 Sep; 30(9):1059-67. PubMed ID: 26004398
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Site-specific tumor grading system in colorectal cancer: multicenter pathologic review of the value of quantifying poorly differentiated clusters.
    Ueno H; Hase K; Hashiguchi Y; Shimazaki H; Tanaka M; Miyake O; Masaki T; Shimada Y; Kinugasa Y; Mori Y; Kishimoto M; Kameoka S; Sato Y; Matsuda K; Nakadoi K; Shinto E; Nakamura T; Sugihara K
    Am J Surg Pathol; 2014 Feb; 38(2):197-204. PubMed ID: 24418853
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic significance of grading based on the counting of poorly differentiated clusters in colorectal mucinous adenocarcinoma.
    Barresi V; Reggiani Bonetti L; Ieni A; Domati F; Tuccari G
    Hum Pathol; 2015 Nov; 46(11):1722-9. PubMed ID: 26344416
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinicopathologic impacts of poorly differentiated cluster-based grading system in colorectal carcinoma.
    Kim JW; Shin MK; Kim BC
    J Korean Med Sci; 2015 Jan; 30(1):16-23. PubMed ID: 25552879
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tumor Budding and PDC Grade Are Stage Independent Predictors of Clinical Outcome in Mismatch Repair Deficient Colorectal Cancer.
    Ryan É; Khaw YL; Creavin B; Geraghty R; Ryan EJ; Gibbons D; Hanly A; Martin ST; O'Connell PR; Winter DC; Sheahan K
    Am J Surg Pathol; 2018 Jan; 42(1):60-68. PubMed ID: 29112018
    [TBL] [Abstract][Full Text] [Related]  

  • 8. KRAS, NRAS, BRAF mutations and high counts of poorly differentiated clusters of neoplastic cells in colorectal cancer: observational analysis of 175 cases.
    Barresi V; Bonetti LR; Bettelli S
    Pathology; 2015 Oct; 47(6):551-6. PubMed ID: 26352110
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Colorectal carcinoma grading by quantifying poorly differentiated cell clusters is more reproducible and provides more robust prognostic information than conventional grading.
    Barresi V; Reggiani Bonetti L; Branca G; Di Gregorio C; Ponz de Leon M; Tuccari G
    Virchows Arch; 2012 Dec; 461(6):621-8. PubMed ID: 23093109
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Analysis of KRAS, NRAS, PIK3CA, and BRAF mutational profile in poorly differentiated clusters of KRAS-mutated colon cancer.
    Reggiani Bonetti L; Barresi V; Bettelli S; Caprera C; Manfredini S; Maiorana A
    Hum Pathol; 2017 Apr; 62():91-98. PubMed ID: 28025078
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Poorly differentiated clusters: prognostic significance in colorectal carcinomas immunohistochemistry images.
    Jurescu A; Văduva A; Tăban S; Gheju A; Olteanu G; Mihai I; Lăzureanu C; Cornianu M; Lazăr F; Dema A
    Pol J Pathol; 2019; 70(4):235-245. PubMed ID: 32146792
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic significance of CDX2 immunoexpression in poorly differentiated clusters of colorectal carcinoma.
    Reggiani Bonetti L; Lionti S; Vitarelli E; Barresi V
    Virchows Arch; 2017 Dec; 471(6):731-741. PubMed ID: 28819729
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Histopathological variables in liver metastases of patients with stage IV colorectal cancer: potential prognostic relevance of poorly differentiated clusters.
    Lionti S; Reggiani Bonetti L; Bettelli S; Spallanzani A; Gelsomino F; Barresi V
    Hum Pathol; 2018 Aug; 78():115-124. PubMed ID: 29715463
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The presence of poorly differentiated clusters predicts survival in stage II colorectal cancer.
    Ammendola S; Turri G; Marconi I; Burato G; Pecori S; Tomezzoli A; Conti C; Pedrazzani C; Barresi V
    Virchows Arch; 2021 Feb; 478(2):241-248. PubMed ID: 32577812
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Histologic prognostic markers in stage IIA colorectal cancer: a comparative study.
    Barresi V; Reggiani Bonetti L; Ieni A; Branca G; Tuccari G
    Scand J Gastroenterol; 2016 Mar; 51(3):314-20. PubMed ID: 26554618
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Poorly differentiated clusters and tumor budding are important prognostic factors in colorectal carcinomas.
    Jurescu A; Dema A; Văduva A; Gheju A; Vița O; Barna R; Lăzureanu C; Cornianu M; Tăban S; Duță C; Pantea S
    Bosn J Basic Med Sci; 2022 Apr; 22(2):164-177. PubMed ID: 34480464
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A novel histologic grading scheme based on poorly differentiated clusters is applicable to treated rectal cancer and is associated with established histopathological prognosticators.
    Yang M; Rehman AU; Zuo C; Sheehan CE; Lee EC; Lin J; Zhao Z; Choi E; Lee H
    Cancer Med; 2016 Jul; 5(7):1510-8. PubMed ID: 27165693
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Poorly differentiated clusters (PDCs) as a novel histological predictor of nodal metastases in pT1 colorectal cancer.
    Barresi V; Branca G; Ieni A; Reggiani Bonetti L; Baron L; Mondello S; Tuccari G
    Virchows Arch; 2014 Jun; 464(6):655-62. PubMed ID: 24771119
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Histological grading based on poorly differentiated clusters is predictive of tumour response and clinical outcome in rectal carcinoma treated with neoadjuvant chemoradiotherapy.
    Reggiani Bonetti L; Lionti S; Domati F; Pagliani G; Mattioli E; Barresi V
    Histopathology; 2017 Sep; 71(3):393-405. PubMed ID: 28425130
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The number of metastatic lymph nodes exhibiting poorly differentiated clusters predicts survival in patients with pStage III colorectal cancer.
    Kinoshita O; Kishimoto M; Murayama Y; Kuriu Y; Nakanishi M; Sakakura C; Otsuji E; Yanagisawa A
    Int J Colorectal Dis; 2016 Feb; 31(2):283-90. PubMed ID: 26412250
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.